Welcome, Guest
Username: Password: Remember me
General
  • Page:
  • 1

TOPIC: Azaya deal completed

Azaya deal completed 15 Feb 2017 06:36 #8824

  • myownhedgefund
  • myownhedgefund's Avatar Topic Author
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 2860
  • Thank you received: 204
SAN DIEGO, Feb. 15, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (CYTX) today announced it has completed its acquisition of assets of privately held Azaya Therapeutics, Inc., a leader in the research, development and manufacturing of nanoparticle therapeutics (the “Acquisition”). The Acquisition provides Cytori with a proprietary liposomal nanoparticle technology platform that is intended to complement Cytori’s leadership position in regenerative medicine and expand its pipeline with two promising nanoparticle oncology drugs.
“This acquisition is a very important step in the development of Cytori,” said Dr. Marc Hedrick, President and Chief Executive Officer of Cytori. “The Acquisition provides Cytori both a near term opportunity to seek regulatory approval in Europe for the acquired ATI-0918 drug candidate, a generic form of nanoparticle encapsulated doxorubicin, with the goal of launching it in Europe as early as 2019, and bolsters Cytori’s early and intermediate stage pipeline with new drug candidates in regenerative medicine and oncology”.  
Cytori plans to develop nanoparticle-based therapeutics under the name Cytori Nanomedicine™ in the areas of oncology and regenerative medicine. In addition to ATI-0918, the generic nanoparticle encapsulated doxorubicin, Cytori has added the clinical stage ATI-1123 drug candidate, a protein-stabilized nanoparticle formulation of docetaxel and a preclinical stage regenerative medicine drug candidate for scleroderma.

Please Log in or Create an account to join the conversation.

Azaya deal completed 15 Feb 2017 06:45 #8825

  • rodney.strongg
  • rodney.strongg's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 1362
  • Thank you received: 19
Good news - a week earlier than I thought was likely - initial pre-mkt trade of 900 shares at 2.20.

Please Log in or Create an account to join the conversation.

  • Page:
  • 1
Time to create page: 0.062 seconds

Copyright Information

Copyright Fas Kuiters © 2016 young-foxes.com. All Rights Reserved.
This page is made with Joomla CMS and its various templates designed by Fas Kuiters with the excellent Themler tool.

 

 

Shared Spreadsheet Links

DOV´s Revised Projections for the Periods 2017 until 2020

Shareble link : HERE

Fas Kuiters Websites